COPD: Page 3
Human studies approved for lung denervation device
April 4, 2024
Phase 1 trial begins for COPD treatment
March 29, 2024
AstraZeneca begins phase III clinical trial on Breztri
March 18, 2024
ALA releases new COPD Trends brief
March 11, 2024
First patient dosed in phase 2 COPD treatment trial
March 11, 2024
Dupixent accepted for FDA priority review
March 4, 2024
Gut microbiome plays pivotal role in COPD development
February 28, 2024